And that patient who was in one of the earliest cohort is still a CR after nearly 2 years later, also the update showed few PR and multiple SD on low dosage. Best time to enter or buy more as it seem the market has forgotten this........
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)